Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (731-740 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|August 19, 2024
Effective treatment of refractory monoclonal gammopathy-associated pure red cell aplasia with isatuximab, pomalidomide and dexamethasoneChristian Sebastian Michel, Eva Marie Fehr, Hildegard Nolte, et al.
Ejhaem|August 19, 2024
Fostamatinib for immune thrombocytopenic purpura in adult patients: A systematic review and meta-analysisRoger Kou, Lucy Zhao, Daniel Tham, et al.
Ejhaem|August 19, 2024
Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamabSyed Naqvi, Asis Shrestha, Marah Alzubi, et al.
Ejhaem|August 19, 2024
Similarities and differences of bone marrow and peripheral blood samples from acute myeloid leukemia patients in terms of cellular heterogeneity and ex-vivo drug sensitivityGulser Caliskan, Yudi Pawitan, Trung Nghia Vu
Ejhaem|August 19, 2024
Effective treatment of relapsed/refractory CD19-positive B/T-type mixed-phenotype acute leukemia with blinatumomab: A case reportMasanori Aoki, Maho Ishikawa, Tsugumi Sato, et al.
Ejhaem|June 19, 2024
Positive impacts of universal newborn screening on the outcome of children with sickle cell disease in the province of Quebec: A retrospective cohort studyCosta Kazadi, Thierry Ducruet, Stéphanie Forté, et al.
Ejhaem|June 19, 2024
Systematic review and evidence gap assessment of the clinical, quality of life, and economic burden of alpha-thalassemiaKhaled M Musallam, Vip Viprakasit, Louise Lombard, et al.
Ejhaem|June 19, 2024
Stable engraftment, as well as graft versus host disease-free and relapse-free survival brought by the combination of CD7 targeted universal chimeric antigen receptor-T, and donor hemopoietic stem cells: Indication of a case reportShiqi Li, Zhongtao Yuan, Lin Liu, et al.
Ejhaem|June 19, 2024
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in ItalyFrancesca Fazio, Maria Teresa Petrucci, Laura Corvatta, et al.
Ejhaem|June 19, 2024
Correction to "Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis"
Pageof 93

Showing results (731-740 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|August 19, 2024
Effective treatment of refractory monoclonal gammopathy-associated pure red cell aplasia with isatuximab, pomalidomide and dexamethasoneChristian Sebastian Michel, Eva Marie Fehr, Hildegard Nolte, et al.
Ejhaem|August 19, 2024
Fostamatinib for immune thrombocytopenic purpura in adult patients: A systematic review and meta-analysisRoger Kou, Lucy Zhao, Daniel Tham, et al.
Ejhaem|August 19, 2024
Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamabSyed Naqvi, Asis Shrestha, Marah Alzubi, et al.
Ejhaem|August 19, 2024
Similarities and differences of bone marrow and peripheral blood samples from acute myeloid leukemia patients in terms of cellular heterogeneity and ex-vivo drug sensitivityGulser Caliskan, Yudi Pawitan, Trung Nghia Vu
Ejhaem|August 19, 2024
Effective treatment of relapsed/refractory CD19-positive B/T-type mixed-phenotype acute leukemia with blinatumomab: A case reportMasanori Aoki, Maho Ishikawa, Tsugumi Sato, et al.
Ejhaem|June 19, 2024
Positive impacts of universal newborn screening on the outcome of children with sickle cell disease in the province of Quebec: A retrospective cohort studyCosta Kazadi, Thierry Ducruet, Stéphanie Forté, et al.
Ejhaem|June 19, 2024
Systematic review and evidence gap assessment of the clinical, quality of life, and economic burden of alpha-thalassemiaKhaled M Musallam, Vip Viprakasit, Louise Lombard, et al.
Ejhaem|June 19, 2024
Stable engraftment, as well as graft versus host disease-free and relapse-free survival brought by the combination of CD7 targeted universal chimeric antigen receptor-T, and donor hemopoietic stem cells: Indication of a case reportShiqi Li, Zhongtao Yuan, Lin Liu, et al.
Ejhaem|June 19, 2024
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in ItalyFrancesca Fazio, Maria Teresa Petrucci, Laura Corvatta, et al.
Ejhaem|June 19, 2024
Correction to "Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis"
Pageof 93